The Roundup cancer lawsuit is one of the largest mass tort cases in American history, and it’s still paying out in 2026. Bayer AG, which purchased Monsanto in 2018, has already spent over $10.9 billion settling claims from people who developed cancer after using Roundup weed killer.
If you or someone you love was diagnosed with cancer after regular Roundup exposure, you may still have time to file a claim. Thousands of cases remain active, and new lawsuits continue entering the system.
This guide covers everything you need to know for 2026. You’ll find settlement amounts, payout ranges, eligibility rules, filing steps, tax details, and critical deadlines.
Here’s something most people don’t realize: individual Roundup verdicts have reached as high as $2 billion before reduction on appeal. Even average settlements fall in the six-figure range.
Roundup Cancer Lawsuit
A Roundup cancer lawsuit is a personal injury or wrongful death claim filed against Bayer AG (formerly Monsanto) alleging that glyphosate-based Roundup herbicide caused the plaintiff’s cancer. These lawsuits accuse Monsanto of knowing about cancer risks for decades and failing to warn consumers.
The litigation traces back to 2015, when the International Agency for Research on Cancer (IARC), a branch of the World Health Organization, classified glyphosate as “probably carcinogenic to humans.” That finding opened the floodgates.
By 2024, more than 100,000 individual claims had been filed against Bayer in courts across the country. Many were consolidated under multidistrict litigation (MDL) No. 2741 in the U.S. District Court for the Northern District of California, overseen by Judge Vince Chhabria.
The litigation isn’t a single class action. Each plaintiff files their own claim based on their specific cancer diagnosis, exposure history, and damages.
| Key Fact | Detail |
|---|---|
| Defendant | Bayer AG (Monsanto) |
| MDL Number | 2741 |
| Court | N.D. California |
| Presiding Judge | Judge Vince Chhabria |
| Total Claims Filed | Over 100,000 |
| Settlement Fund | $10.9 billion (2020) |
Bayer has repeatedly denied that Roundup causes cancer, pointing to EPA findings that glyphosate is not likely carcinogenic. But juries have disagreed, handing down massive verdicts in multiple bellwether trials.
Roundup Cancer Lawsuit Update 2026
As of 2026, the Roundup cancer lawsuit remains active with both new filings and ongoing settlement disbursements. Bayer continues resolving remaining claims from its massive settlement fund while fighting select cases at trial.

Several key developments define the 2026 landscape of this litigation. Bayer attempted to create a $2 billion class deal to resolve future claims from Roundup users who hadn’t yet been diagnosed with cancer. That proposal faced fierce opposition and was rejected by Judge Chhabria in 2021.
Since then, Bayer has pursued a different strategy. The company announced plans to replace glyphosate in its residential U.S. lawn and garden products starting in 2023, switching to alternative active ingredients. That transition is now largely complete for consumer products, though glyphosate remains in commercial agricultural formulations.
In 2025 and into 2026, Bayer has continued settling individual cases while also pursuing appeals on key verdicts. The company’s legal costs have exceeded $16 billion when combining settlements, verdicts, and legal fees.
Quick Facts for 2026:
- New claims are still being accepted in many states
- Bayer has set aside additional reserves beyond the original $10.9 billion
- EPA’s registration review of glyphosate remains a factor in ongoing litigation
- Several state courts continue to schedule individual trials
- The Supreme Court declined to hear Bayer’s preemption argument in 2024, keeping the door open for state-level claims
Roundup Cancer Lawsuit Settlement Amounts
Roundup cancer lawsuit settlement amounts typically range from $5,000 to over $2 million per person, depending on the severity of the cancer, duration of Roundup exposure, strength of medical evidence, and the claimant’s age and overall damages.
Not every case is worth the same amount. Bayer and plaintiff attorneys use a tiered system to categorize claims by severity and assign value ranges.
| Settlement Tier | Case Description | Estimated Range |
|---|---|---|
| Tier 1 (Highest) | Non-Hodgkin lymphoma with long-term exposure, strong causation evidence | $150,000 to $2,000,000+ |
| Tier 2 | NHL with moderate exposure, solid medical records | $75,000 to $250,000 |
| Tier 3 | Other lymphatic cancers with documented Roundup use | $25,000 to $100,000 |
| Tier 4 (Lowest) | Weaker causation evidence, limited exposure history | $5,000 to $50,000 |
| Wrongful Death | Deceased plaintiff, cancer attributed to Roundup | $100,000 to $1,000,000+ |
The three bellwether trial verdicts paint a picture of what juries are willing to award:
- Johnson v. Monsanto (2018): $289 million verdict, later reduced to $20.5 million
- Hardeman v. Monsanto (2019): $80 million verdict, reduced to $25 million
- Pilliod v. Monsanto (2019): $2 billion verdict, reduced to $86.7 million
These reductions happened on appeal, but they still represent enormous payouts. Most individual settlements fall well below verdict amounts because settling avoids the risk and delay of trial.
Roundup Cancer Lawsuit Payout Per Person
The average Roundup cancer lawsuit payout per person in settled cases is estimated between $100,000 and $175,000, though individual payouts vary dramatically based on case-specific factors.
Think of it like car insurance claims. A fender bender pays out differently than a totaled vehicle. Your payout depends on what happened to you specifically.
Factors that increase your payout include:
- Cancer severity: Aggressive or advanced-stage cancers command higher settlements
- Exposure duration: Using Roundup for 10+ years strengthens your claim
- Medical expenses: Higher documented treatment costs raise the settlement value
- Lost income: If cancer forced you out of work, that adds to your damages
- Age at diagnosis: Younger plaintiffs with more lost life-years tend to receive higher amounts
- Quality of records: Strong medical records linking cancer to glyphosate exposure boost value
Factors that lower your payout include limited exposure history, a cancer type with weaker scientific links to glyphosate, or gaps in medical documentation.
One thing to remember: payout per person is a gross figure. After attorney fees, litigation costs, and medical liens are deducted, your net check will be lower. We cover those deductions in later sections.
Key Takeaway: Settlement amounts range from $5,000 to over $2 million, with the average individual payout falling between $100,000 and $175,000 depending on cancer severity, exposure history, and the strength of your documentation.
Roundup Weed Killer Cancer Lawsuit
The Roundup weed killer cancer lawsuit specifically targets the product’s active ingredient, glyphosate, and Monsanto’s decades-long marketing of Roundup as safe for home and commercial use.
Roundup has been the world’s most widely used herbicide since the 1970s. Monsanto marketed it to homeowners, gardeners, landscapers, farmers, and groundskeepers as a safe, effective way to kill weeds. What those users didn’t know, the lawsuits allege, is that internal Monsanto documents showed the company was aware of potential cancer links.
Court documents unsealed during litigation, often called the “Monsanto Papers,” revealed internal communications suggesting the company ghostwrote scientific studies, pressured regulators, and worked to discredit independent research linking glyphosate to cancer.
These revelations were devastating in the courtroom. Juries in all three bellwether trials found that Monsanto acted with malice or oppression, which is why they awarded punitive damages on top of compensatory damages.
Key claims in the Roundup weed killer cancer lawsuit include:
- Monsanto failed to warn users about cancer risks on product labels
- The company manipulated scientific research to hide dangers
- Roundup’s formulation (glyphosate plus surfactants) may be more toxic than glyphosate alone
- Monsanto prioritized profits over consumer safety for decades
Bayer, which acquired Monsanto for $63 billion in 2018, inherited this entire legal mess. The acquisition is now widely considered one of the worst corporate deals in modern history due to the litigation costs.
Roundup Causes Cancer Lawsuit
The Roundup causes cancer lawsuit rests on the scientific argument that glyphosate, Roundup’s primary ingredient, is a probable human carcinogen linked primarily to non-Hodgkin lymphoma and other cancers of the lymphatic system.
The scientific debate has two sides. On one side, the IARC concluded in March 2015 that glyphosate is “probably carcinogenic to humans” (Group 2A classification). This assessment reviewed multiple epidemiological studies and found a clear association between glyphosate exposure and cancer.
On the other side, the U.S. EPA published findings stating glyphosate is “not likely to be carcinogenic to humans.” Bayer leans heavily on this EPA finding in its defense.
Here’s what matters in court: juries have consistently sided with the IARC position. Three separate juries in three separate trials found that Roundup was a substantial contributing factor to the plaintiffs’ cancer.
| Organization | Finding on Glyphosate |
|---|---|
| IARC (WHO) | “Probably carcinogenic to humans” (2015) |
| U.S. EPA | “Not likely to be carcinogenic to humans” |
| California OEHHA | Listed as known carcinogen under Prop 65 |
| European Food Safety Authority | “Unlikely to pose carcinogenic hazard” |
| ATSDR (U.S. HHS) | Found associations with cancer in some studies |
The mixed regulatory picture actually helped plaintiffs. Jurors concluded that Monsanto cherry-picked favorable regulatory findings while suppressing research that showed harm. That pattern of concealment drove the massive punitive damages awards.
Roundup Lawsuit Eligibility 2026
To be eligible for a Roundup lawsuit in 2026, you generally must have a documented history of Roundup or glyphosate-based herbicide exposure AND a diagnosis of non-Hodgkin lymphoma or another qualifying cancer.
Not everyone who used Roundup qualifies. The claim must connect your product use to a specific cancer diagnosis. Casual, one-time use of Roundup rarely meets the threshold for a viable lawsuit.
Basic eligibility requirements include:
- Exposure: You used Roundup, Ranger Pro, or another glyphosate product regularly over a period of months or years
- Diagnosis: You developed non-Hodgkin lymphoma or another linked cancer (see cancer types section below)
- Timing: Your cancer diagnosis came after your Roundup exposure
- Documentation: You have medical records confirming your diagnosis and can provide evidence of product usage
- Statute of limitations: You are within your state’s filing deadline (varies by state)
| Eligible | Not Eligible |
|---|---|
| Regular Roundup users diagnosed with NHL | One-time Roundup users with no cancer |
| Landscapers, farmers, groundskeepers with cancer | People who lived near fields but never handled the product (case-by-case) |
| Family members filing wrongful death claims | People with no documented exposure history |
| Users diagnosed with qualifying cancer types | People with cancers not linked to glyphosate |
People who qualify often include agricultural workers, nursery employees, park maintenance crews, golf course groundskeepers, homeowners with large properties, and highway department workers who sprayed roadsides.
Key Takeaway: You qualify for a 2026 Roundup lawsuit if you regularly used glyphosate-based products, received a qualifying cancer diagnosis, and can file within your state’s statute of limitations.
Roundup Cancer Types Linked to Glyphosate
Non-Hodgkin lymphoma (NHL) is the cancer most strongly linked to glyphosate exposure, but several other cancer types have been associated with Roundup use in scientific studies and legal claims.
The IARC review and subsequent epidemiological research identified multiple cancer types with potential connections to glyphosate. NHL remains the strongest link and forms the basis of most successful claims.
Cancer types linked to Roundup in lawsuits and studies:
- Non-Hodgkin lymphoma (all subtypes): Strongest scientific and legal support
- Diffuse large B-cell lymphoma (DLBCL): A common NHL subtype frequently seen in Roundup cases
- Follicular lymphoma: Another NHL subtype with documented glyphosate associations
- Chronic lymphocytic leukemia (CLL): Some studies show elevated risk with glyphosate exposure
- Mantle cell lymphoma: Less common but included in NHL-related claims
- Hairy cell leukemia: Rare form with some epidemiological links
- B-cell lymphoma: Broad category covering several subtypes seen in litigation
- T-cell lymphoma: Less frequently cited but included in some claims
- Multiple myeloma: Some studies suggest association, though weaker than NHL
| Cancer Type | Strength of Link | Common in Lawsuits? |
|---|---|---|
| Non-Hodgkin Lymphoma | Strong | Yes, most common |
| Diffuse Large B-Cell Lymphoma | Strong | Yes |
| Follicular Lymphoma | Moderate to Strong | Yes |
| Chronic Lymphocytic Leukemia | Moderate | Yes |
| Multiple Myeloma | Moderate | Sometimes |
| Hairy Cell Leukemia | Moderate | Sometimes |
| T-Cell Lymphoma | Weaker | Less common |
If you have a cancer diagnosis that falls outside these categories, that doesn’t automatically disqualify your claim. New research continues to emerge, and some attorneys accept cases involving other cancers if the exposure evidence is strong enough.
Roundup Non-Hodgkin Lymphoma Lawsuit
The Roundup non-Hodgkin lymphoma lawsuit is the cornerstone of the entire Roundup litigation, as NHL has the strongest scientific evidence connecting it to glyphosate exposure. Nearly every major Roundup verdict and settlement has involved an NHL diagnosis.
Non-Hodgkin lymphoma is a group of blood cancers that develop in the lymphatic system. There are more than 60 subtypes. Symptoms often include swollen lymph nodes, unexplained weight loss, fatigue, fever, and night sweats.
All three landmark bellwether trial plaintiffs had NHL:
- Dewayne Johnson was a school groundskeeper who sprayed Roundup regularly. He was diagnosed with NHL in 2014 and won a $289 million verdict in 2018 (reduced to $20.5 million).
- Edwin Hardeman used Roundup on his property for over 25 years. His NHL diagnosis led to an $80 million verdict in 2019 (reduced to $25 million).
- Alva and Alberta Pilliod were a married couple who both developed NHL after using Roundup for over 30 years. Their combined verdict was $2 billion in 2019 (reduced to $86.7 million).
These cases established a powerful legal precedent. Juries found that Roundup was a substantial factor in causing each plaintiff’s NHL.
Why NHL cases are the strongest:
- The IARC specifically cited NHL evidence in its glyphosate classification
- Multiple meta-analyses show a 41% increased risk of NHL among glyphosate users
- Agricultural health studies consistently identify the NHL-glyphosate connection
- All three trial verdicts validated the link before juries
If you have NHL and used Roundup, your case sits in the strongest possible category for settlement value.
Key Takeaway: Non-Hodgkin lymphoma cases form the backbone of Roundup litigation, backed by all three bellwether verdicts and the IARC’s 2015 carcinogen classification of glyphosate.
How to File a Roundup Cancer Lawsuit
To file a Roundup cancer lawsuit in 2026, you need to gather your medical records, document your Roundup exposure history, contact an attorney experienced in Roundup litigation, and file your claim before your state’s statute of limitations expires.
The process isn’t as complicated as most people fear. Here’s a step-by-step breakdown.
Step 1: Confirm your eligibility. Make sure you have a qualifying cancer diagnosis (primarily NHL) and a history of regular Roundup use. One-time exposure cases are very difficult to win.
Step 2: Collect your documents. Gather medical records showing your cancer diagnosis, treatment history, and any medical opinions linking your cancer to chemical exposure. Collect any purchase receipts, employment records, or photographs showing Roundup use.
Step 3: Contact a Roundup attorney. Most Roundup lawyers work on a contingency fee basis, meaning you pay nothing upfront. They only collect a percentage if you win or settle.
Step 4: Your attorney files the complaint. This is done in the appropriate court. New cases may be filed in state courts or consolidated into the existing MDL in California.
Step 5: Discovery and evaluation. Your attorney and Bayer’s lawyers exchange evidence. Your case is evaluated and assigned to a settlement tier.
Step 6: Settlement negotiation or trial. Most cases settle. A small percentage go to trial.
| Step | Action | Timeline |
|---|---|---|
| Step 1 | Confirm eligibility | 1 to 2 days |
| Step 2 | Gather documents | 1 to 4 weeks |
| Step 3 | Consult attorney | 1 to 2 weeks |
| Step 4 | File complaint | Attorney handles this |
| Step 5 | Discovery | 6 to 18 months |
| Step 6 | Settlement or trial | 1 to 3+ years |
Roundup Lawsuit Timeline 2026
The Roundup lawsuit timeline in 2026 reflects a litigation that has been active for over eight years, with major milestones stretching from 2015 through the present day.
Understanding where the litigation stands in 2026 helps you set realistic expectations for your own claim.
| Year | Milestone |
|---|---|
| 2015 | IARC classifies glyphosate as “probably carcinogenic” |
| 2016 | First Roundup cancer lawsuits filed; MDL 2741 created |
| 2018 | Johnson v. Monsanto: first trial verdict ($289M) |
| 2018 | Bayer acquires Monsanto for $63 billion |
| 2019 | Hardeman verdict ($80M) and Pilliod verdict ($2B) |
| 2020 | Bayer announces $10.9 billion settlement fund |
| 2021 | Judge Chhabria rejects Bayer’s future claims class proposal |
| 2022-2023 | Individual settlements processed; Bayer removes glyphosate from consumer products |
| 2024 | Supreme Court declines Bayer’s preemption appeal |
| 2025 | Bayer adds additional settlement reserves; new claims continue |
| 2026 | Ongoing settlements, new filings accepted, individual state trials continue |
The Supreme Court’s 2024 decision not to hear Bayer’s case was a turning point. Bayer had argued that EPA approval of glyphosate should preempt (override) state-level failure-to-warn claims. The Court’s refusal to take the case meant that cancer victims could continue suing in state courts.
For new claimants entering the system in 2026, expect the process to take 12 to 36 months from filing to settlement. Cases headed for trial may take longer.
Roundup Lawsuit Deadline 2026
Roundup lawsuit deadlines in 2026 depend on your state’s statute of limitations for personal injury claims, which typically ranges from 1 to 6 years from the date of cancer diagnosis or from when you reasonably should have connected your cancer to Roundup.
This is where things get tricky. Every state has its own rules.
| State | Statute of Limitations | Discovery Rule? |
|---|---|---|
| California | 2 years | Yes |
| Texas | 2 years | Yes |
| Florida | 4 years (changed in 2024 from 4 to 2 for new claims) | Yes |
| New York | 3 years | Yes |
| Illinois | 2 years | Yes |
| Pennsylvania | 2 years | Yes |
| Ohio | 2 years | Yes |
| Georgia | 2 years | Yes |
| Missouri | 5 years | Yes |
| Montana | 3 years | Yes |
The “discovery rule” is critical here. In most states, the statute of limitations clock doesn’t start ticking on the day you were diagnosed. It starts when you knew (or should have known) that Roundup might have caused your cancer.
This means if you were diagnosed in 2020 but only learned about the Roundup cancer connection in 2024, your filing clock may have started in 2024, not 2020. An attorney can evaluate your specific situation.
The bottom line: do not assume it’s too late. Contact a Roundup attorney to check your state’s deadline before giving up on a potentially valuable claim.
Key Takeaway: Statutes of limitations vary by state, and the discovery rule may extend your filing deadline, so verify your specific deadline with an attorney before assuming your claim has expired.
Is It Too Late to File a Roundup Lawsuit
No, it is generally not too late to file a Roundup lawsuit in 2026, as long as you fall within your state’s statute of limitations and meet the basic eligibility criteria.
Many people assume they’ve missed their window. That’s not necessarily true. Here’s why.
First, the discovery rule can push your deadline out. If you were recently diagnosed, your clock may have just started. If you were diagnosed years ago but only recently made the connection to Roundup, you might still be within the window.
Second, Bayer continues to accept and process new claims. The company has allocated reserves beyond the original $10.9 billion settlement fund to handle incoming lawsuits.
Third, some states have longer statutes of limitations. Missouri allows 5 years. Louisiana allows 1 year, which is the shortest in the country.
Situations where you may still be eligible:
- You were diagnosed within the last 1 to 5 years (depending on your state)
- You only recently learned that Roundup could have caused your cancer
- You are filing a wrongful death claim for a family member who passed away from cancer linked to Roundup
- You are a minor or were incapacitated, as many states toll (pause) the statute of limitations in these cases
Situations where it may be too late:
- You were diagnosed many years ago and knew about the Roundup connection but did not file
- Your state has a short statute of limitations and the discovery rule doesn’t apply to your facts
- You have no documented Roundup exposure history
The only way to know for sure is to have an attorney review your specific circumstances.
Roundup Cancer Lawsuit Evidence
Strong evidence in a Roundup cancer lawsuit includes documented exposure history, medical records confirming a qualifying cancer diagnosis, expert medical opinions, and scientific studies linking glyphosate to cancer.
Building a winning case isn’t about one smoking gun. It’s about stacking multiple layers of evidence that tell a consistent story.
Types of evidence used in Roundup cases:
- Medical records: Diagnosis reports, pathology results, treatment records, and oncologist statements
- Exposure documentation: Purchase receipts for Roundup, employment records showing herbicide use, photographs or videos of spraying, witness testimony from coworkers or family members
- Expert testimony: Oncologists, toxicologists, and epidemiologists who can testify about the glyphosate-cancer link
- Scientific studies: The IARC monograph, Agricultural Health Study data, meta-analyses on NHL risk
- Internal Monsanto documents: The “Monsanto Papers” showing the company’s knowledge of cancer risks and efforts to suppress research
- Product usage records: How often you sprayed, how many years, whether you wore protective equipment
Cases with the strongest evidence typically involve plaintiffs who used Roundup professionally (landscapers, farmers, groundskeepers) over many years, because their exposure is well-documented through employment records.
| Evidence Type | Impact on Case Value |
|---|---|
| Medical diagnosis of NHL | Very High |
| 10+ years of documented use | High |
| Employment records as landscaper/farmer | High |
| Purchase receipts | Moderate |
| Witness testimony | Moderate |
| Photos/videos of spraying | Moderate |
| Family history of cancer (complicating factor) | May reduce value |
Even if you don’t have purchase receipts, your attorney can build a case using other evidence. Testimony from neighbors, coworkers, or family members who saw you using Roundup counts.
Roundup Cancer Lawsuit Attorney Fees
Attorney fees in a Roundup cancer lawsuit typically range from 25% to 40% of your total settlement or verdict amount, with most Roundup lawyers charging on a contingency fee basis.
Contingency fee means you pay nothing out of pocket. Zero upfront costs. Your lawyer fronts all expenses and only gets paid if you win or settle. If you lose, you owe nothing.
Typical fee structure breakdown:
| Component | Percentage/Amount |
|---|---|
| Attorney contingency fee | 25% to 40% of recovery |
| Litigation costs (filing fees, experts, etc.) | Deducted from recovery, typically $5,000 to $20,000 |
| Medical lien repayments | Varies, deducted from recovery |
| Your net payout | Remaining balance after deductions |
Here’s a real-world example. Say your case settles for $200,000 with a 33% attorney fee:
- Attorney fee: $66,000
- Litigation costs: $10,000 (estimated)
- Medical liens: $15,000 (estimated)
- Your net check: $109,000
The exact percentage depends on several factors. Cases that settle before trial often carry a lower fee percentage (around 25% to 33%). Cases that go to trial typically bump to 33% to 40% because the attorney’s workload and risk increase significantly.
What to ask your attorney before signing:
- What is the exact contingency percentage?
- Does the percentage increase if the case goes to trial?
- Are litigation costs deducted before or after the attorney fee is calculated?
- Will I owe anything if we lose?
Shopping around is acceptable. Get consultations from 2 to 3 attorneys and compare fee structures before committing.
Key Takeaway: Most Roundup attorneys charge 25% to 40% of your recovery on a contingency basis, meaning you pay nothing upfront and only pay if you win or settle your case.
Roundup Settlement Tax Implications
Most Roundup cancer lawsuit settlement proceeds for physical injury or sickness are not taxable under federal law, but portions designated as punitive damages, interest, or emotional distress (unrelated to physical injury) may be taxed.
Tax treatment of lawsuit settlements trips up a lot of people. Here’s how it breaks down.
Under IRS Section 104(a)(2), compensation received for personal physical injuries or physical sickness is excluded from gross income. Since Roundup settlements compensate for cancer (a physical illness), the compensatory portion is typically tax-free.
| Settlement Component | Taxable? |
|---|---|
| Compensatory damages for cancer | No (tax-free) |
| Medical expense reimbursement | No (tax-free, but see note below) |
| Lost wages compensation | Possibly (depends on allocation) |
| Punitive damages | Yes (fully taxable) |
| Interest on settlement | Yes (taxable as income) |
| Emotional distress (tied to physical injury) | No (tax-free) |
| Emotional distress (not tied to physical injury) | Yes (taxable) |
There’s one catch with medical expenses. If you previously deducted medical expenses on your tax returns and then received a settlement reimbursing those same expenses, the IRS may consider that portion taxable because you already received the tax benefit.
A smart move: work with a tax professional before your settlement check arrives. They can help you structure the allocation of settlement proceeds to minimize your tax burden. How the settlement agreement categorizes different components matters enormously.
State taxes add another layer. Some states follow federal treatment; others have their own rules. Check your state’s specific tax code for lawsuit settlement income.
Roundup Lawsuit Funding Options
Roundup lawsuit funding, sometimes called pre-settlement funding or lawsuit loans, provides plaintiffs with cash advances against their expected settlement while their case is still pending.
Waiting years for a Roundup settlement to finalize while battling cancer is brutal. Medical bills pile up. Income drops. Pre-settlement funding can bridge that gap.
How pre-settlement funding works:
- A funding company evaluates your case and its expected settlement value
- If approved, you receive a cash advance (typically $500 to $100,000)
- You repay the advance plus fees/interest only if you win or settle
- If you lose your case, you owe nothing (non-recourse funding)
| Funding Detail | Info |
|---|---|
| Typical advance amount | $500 to $100,000 |
| Repayment trigger | Only if you win or settle |
| Interest rates | 15% to 60% annually (varies by company) |
| Approval time | 24 to 72 hours |
| Risk to plaintiff | None if case is lost |
The downsides are real. Interest rates on pre-settlement funding are high, sometimes extremely high. A $10,000 advance at 36% annual interest that takes 2 years to settle could cost you $17,200 to repay. That eats into your net settlement significantly.
When funding makes sense:
- You can’t cover basic living expenses while waiting
- Medical treatment costs require immediate payment
- You’re at risk of losing housing or utilities
When to avoid it:
- Your case is likely to settle within a few months
- You can manage expenses without borrowing
- The interest rate exceeds 40% annually
Always discuss pre-settlement funding with your attorney first. Some attorneys discourage it because of the high costs, while others have relationships with reputable funding companies that offer better rates.
Key Takeaway: Pre-settlement funding can provide needed cash during your Roundup lawsuit, but high interest rates mean you should exhaust other financial options first and carefully compare funding companies before accepting any advance.
Frequently Asked Questions
How much money can I get from a Roundup cancer lawsuit in 2026?
Individual Roundup cancer lawsuit settlements in 2026 typically range from $5,000 to over $2 million, with the average payout estimated between $100,000 and $175,000.
Your specific amount depends on your cancer type, exposure duration, medical costs, and case strength.
Non-Hodgkin lymphoma cases with long-term, documented exposure receive the highest payouts.
What types of cancer qualify for a Roundup lawsuit?
Non-Hodgkin lymphoma and its subtypes, including diffuse large B-cell lymphoma and follicular lymphoma, are the cancers most strongly linked to Roundup.
Other potentially qualifying cancers include chronic lymphocytic leukemia, hairy cell leukemia, and multiple myeloma.
The strength of your claim depends on the scientific evidence connecting your specific cancer type to glyphosate exposure.
Is Bayer still paying Roundup cancer settlements in 2026?
Yes, Bayer continues to pay Roundup cancer settlements in 2026.
The company has spent more than $10.9 billion since 2020 and has set aside additional reserves for ongoing and new claims.
New lawsuits are still being filed, and Bayer is actively resolving cases through settlement negotiations and, in some instances, trials.
How long does a Roundup cancer lawsuit take to settle?
Most Roundup cancer lawsuits take 12 to 36 months from filing to settlement.
Cases that go to trial can take longer, sometimes 3 to 5 years or more.
The timeline depends on your court’s schedule, the complexity of your case, and whether Bayer chooses to negotiate or fight.
Can I file a Roundup lawsuit if my family member died from cancer?
Yes, if a family member died from cancer linked to Roundup exposure, you may be able to file a wrongful death lawsuit.
Eligible family members typically include spouses, children, and parents of the deceased.
Wrongful death claims follow the same evidence requirements and are subject to your state’s specific wrongful death statute of limitations.
Take Action on Your Roundup Claim
The Roundup cancer lawsuit remains one of the most significant consumer safety cases in U.S. history. Bayer is still paying, courts are still hearing cases, and new claims are still welcome in 2026.
If you used Roundup regularly and were diagnosed with cancer, your clock is ticking. Check your state’s filing deadline. Gather your medical records and any evidence of product use.
Contact a Roundup attorney for a free case evaluation. You’ll pay nothing upfront, and you could recover compensation that helps cover medical bills, lost wages, and the harm you’ve endured.







